Bionano Genomics, Inc. (BNGO): Price and Financial Metrics

Bionano Genomics, Inc. (BNGO): $1.85

0.04 (+2.21%)

POWR Rating

Component Grades













Add BNGO to Watchlist
Sign Up

Industry: Biotech



in industry


  • Sentiment is the dimension where BNGO ranks best; there it ranks ahead of 34.37% of US stocks.
  • The strongest trend for BNGO is in Growth, which has been heading up over the past 177 days.
  • BNGO's current lowest rank is in the Quality metric (where it is better than 1.82% of US stocks).

BNGO Stock Summary

  • BIONANO GENOMICS INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 12.74% of US listed stocks.
  • With a price/sales ratio of 20.76, BIONANO GENOMICS INC has a higher such ratio than 94.1% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.13 for BIONANO GENOMICS INC; that's greater than it is for merely 10.25% of US stocks.
  • If you're looking for stocks that are quantitatively similar to BIONANO GENOMICS INC, a group of peers worth examining would be ASTC, OCX, NTRA, LNSR, and BLZE.
  • BNGO's SEC filings can be seen here. And to visit BIONANO GENOMICS INC's official web site, go to

BNGO Valuation Summary

  • In comparison to the median Healthcare stock, BNGO's price/sales ratio is 311.76% higher, now standing at 21.
  • BNGO's price/sales ratio has moved up 16.2 over the prior 54 months.

Below are key valuation metrics over time for BNGO.

Stock Date P/S P/B P/E EV/EBIT
BNGO 2023-01-20 21.0 1.9 -4.6 -4.3
BNGO 2023-01-19 19.5 1.8 -4.3 -4.0
BNGO 2023-01-18 21.0 1.9 -4.6 -4.3
BNGO 2023-01-17 22.4 2.1 -5.0 -4.6
BNGO 2023-01-13 20.8 1.9 -4.6 -4.3
BNGO 2023-01-12 20.9 1.9 -4.6 -4.3

BNGO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BNGO has a Quality Grade of D, ranking ahead of 7.91% of graded US stocks.
  • BNGO's asset turnover comes in at 0.063 -- ranking 71st of 75 Measuring and Control Equipment stocks.
  • 500 - Internal server error

The table below shows BNGO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.063 0.333 -3.723
2021-03-31 0.082 0.336 -2.825
2020-12-31 0.230 0.326 -4.176
2020-09-30 0.248 0.369 -6.041
2020-06-30 0.352 0.344 -2.947
2020-03-31 0.402 0.312 -2.104

BNGO Price Target

For more insight on analysts targets of BNGO, see our BNGO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $11.50 Average Broker Recommendation 1.12 (Strong Buy)

BNGO Stock Price Chart Interactive Chart >

Price chart for BNGO

BNGO Price/Volume Stats

Current price $1.85 52-week high $4.35
Prev. close $1.81 52-week low $1.16
Day low $1.78 Volume 4,395,900
Day high $1.87 Avg. volume 6,704,544
50-day MA $1.90 Dividend yield N/A
200-day MA $1.97 Market Cap 549.31M

Bionano Genomics, Inc. (BNGO) Company Bio

Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes, which is known as cytogenetics. Its Saphyr system includes an instrument, chip consumables, reagents, and a suite of data analysis tools. The company's Bionano prep kits and labeling kits provide the critical reagents and protocols needed to extract and label high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. It sells its products for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in the United States and Canada, Europe, the Middle East, India, Africa, China, Japan, South Korea, Singapore, and Australia. The company was formerly known as BioNano Genomics, Inc. and changed its name to Bionano Genomics, Inc. in July 2018. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

BNGO Latest News Stream

Event/Time News Detail
Loading, please wait...

BNGO Latest Social Stream

Loading social stream, please wait...

View Full BNGO Social Stream

Latest BNGO News From Around the Web

Below are the latest news stories about BIONANO GENOMICS INC that investors may wish to consider to help them evaluate BNGO as an investment opportunity.

Bionano Laboratories Expands its Clinical Testing Menu with Launch of its First OGM-Based Laboratory Developed Test (LDT) for Hematological Malignancies

SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories today announced the launch of OGM-Dx™ HemeOne™, a laboratory developed test (LDT) based on optical genome mapping (OGM) analysis of blood or bone marrow samples to detect structural variants (SVs) of diagnostic and prognostic utility in individuals with a new or an existing diagnosis of a hematological malignancy. Compared to traditional cytogenetic methods, this OGM-based assay offers a streamlined and improved workflow to assess

Yahoo | January 24, 2023

Watch this stock’s price performance: Bionano Genomics Inc. (NASDAQ:BNGO)

Currently, Bionano Genomics Inc.’s (BNGO) stock is trading at $1.92, marking a gain of 5.19% from last night’s close. At this price, the stock is -55.75% below its 52-week high of $4.35 and 65.95% above its 52-week low of $1.16. Based on the past 30-day period, the stock price is -4.29% below the high and […]

US Post News | January 23, 2023

Bionano Announces Launch of Next-Generation Versions of its Reagent Kits and Chip Consumable, Along with Updates to its Instrument Control and Bionano Access Software for the Optical Genome Mapping Workflow

Bionano Prep SP-G2 (SP-G2) kit offers higher gDNA quality, improved ease-of-use and increased DNA throughputBionano Prep Direct Label and Stain-G2 (DLS-G2) kit offers increased reagent stability and labeling efficiency resulting in significantly faster sample to results workflowSaphyr Chip® G3.3, instrument control software (ICS) version 5.3 and Bionano Access™ software version 1.7.2 offer enhanced evaporation control and workflow robustness enabling for more high coverage samples to be run per

Yahoo | January 23, 2023

3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street

When the curtain closed on 2022, the ageless Dow Jones Industrial Average, widely followed S&P 500, and growth-dependent Nasdaq Composite, respectively finished lower by 9%, 19%, and 33%. It was, collectively, the worst performance for Wall Street in 14 years. This is why most analyst price targets point to upside in equities.

Yahoo | January 23, 2023

After Bionano Genomics Inc. (NASDAQ: BNGO) Surges -605.88% From Highs, What Will It Look Like?

During the last session, Bionano Genomics Inc. (NASDAQ:BNGO)’s traded shares were 6.34 million, with the beta value of the company hitting 2.26. At the end of the trading day, the stock’s price was $1.70, reflecting an intraday loss of -7.10% or -$0.13. The 52-week high for the BNGO share is $4.35, that puts it down … After Bionano Genomics Inc. (NASDAQ: BNGO) Surges -605.88% From Highs, What Will It Look Like? Read More »

Marketing Sentinel | January 20, 2023

Read More 'BNGO' Stories Here

BNGO Price Returns

1-mo 25.85%
3-mo -18.86%
6-mo 0.00%
1-year -4.64%
3-year 71.30%
5-year N/A
YTD 26.71%
2022 -51.17%
2021 -2.92%
2020 148.39%
2019 -76.34%
2018 N/A

Continue Researching BNGO

Want to see what other sources are saying about Bionano Genomics Inc's financials and stock price? Try the links below:

Bionano Genomics Inc (BNGO) Stock Price | Nasdaq
Bionano Genomics Inc (BNGO) Stock Quote, History and News - Yahoo Finance
Bionano Genomics Inc (BNGO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6845 seconds.